Product Images Dapagliflozin
View Photos of Packaging, Labels & Appearance
- Figure_4 - Figure 4
- Figure_5 - Figure 5
- Dapagliflozin Chemical Structure - dapagliflozin struct
- Figure_1 - farxiga fig1
- Figure_10a - figure 10a
- Figure_10b - figure 10b
- Figure_11 - figure 11 01
- Figure_8b - figure 8b
- Figure-9b - figure 9b 01
- Figure_2 - image 01
- Figure_3 - image 02
- Figure_6 - image 03
- Figure_7a - image 04
- Figure-7b - image 05
- Figure-8a - image 06
- Figure-9a - image 07
- Label Image - lbl500907057
Product Label Images
The following 17 images provide visual information about the product associated with Dapagliflozin NDC 50090-7057 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure_4 - Figure 4
Figure_5 - Figure 5
Dapagliflozin Chemical Structure - dapagliflozin struct
Figure_1 - farxiga fig1
Not available.*
Figure_10a - figure 10a
Figure_10b - figure 10b
Figure_11 - figure 11 01
Figure_8b - figure 8b
Figure-9b - figure 9b 01
Figure_2 - image 01
Figure_3 - image 02
Figure_6 - image 03
Figure_7a - image 04
The given text provides information about a study comparing the effects of Dapagliflozin to a placebo in patients. The text includes the percentage of patients with an event in each group, the hazard ratio (HR) and its confidence interval (95% CI), as well as the p-value comparing Dapagliflozin to the placebo. It also includes the number of patients at risk over different time intervals. Based on this information, it appears that Dapagliflozin has a significant effect in reducing the occurrence of the event compared to the placebo.*
Figure-7b - image 05
Not available.*
Figure-8a - image 06
The text contains data comparing the effectiveness of Dapagliflozin versus Placebo in patients. The percentage of patients with a certain condition is mentioned, along with the HR (Hazard Ratio) and P-value. There is also a timeline showing the number of months from randomization and the number of patients at risk for both Dapagliflozin and Placebo.*
Figure-9a - image 07
Label Image - lbl500907057
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
